DH
Definitive Healthcare Corp.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$1.05
+0.96%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 232.7M | 241.5M | 252.2M | 251.4M | 222.7M |
| Cost of Revenue | 65.9M | 58.2M | 54.7M | 47.5M | 42.6M |
| Gross Profit | 166.8M | 183.3M | 197.5M | 203.9M | 180.0M |
| Operating Expenses | |||||
| R&D Expense | 24.0M | 34.8M | 36.5M | 42.4M | 34.9M |
| SG&A Expense | 128.8M | 133.3M | 133.1M | 153.4M | 141.1M |
| General & Admin Expense | 49.6M | 51.6M | 49.3M | 58.9M | 51.6M |
| Selling & Marketing Expense | 79.3M | 81.6M | 83.8M | 94.5M | 89.6M |
| Other Expenses | (142.9M) | 35.8M | 738.7M | 337.9M | 48.0M |
| Total Operating Expenses | 10.0M | 203.9M | 908.3M | 533.7M | 224.1M |
| Cost and Expenses | 75.9M | 262.1M | 963.0M | 581.2M | 266.7M |
| Operating Income (EBIT) | 156.8M | (20.6M) | (710.8M) | (329.8M) | (44.0M) |
| Non-Operating | |||||
| Interest Income | 5.7M | 7.0M | 14.6M | 13.6M | 2.8M |
| Interest Expense | 11.1M | 11.3M | 14.8M | 15.2M | 11.2M |
| Net Interest Income | (5.4M) | (4.3M) | (245.0K) | (1.6M) | (8.4M) |
| Other Non-Op Income/Expense | (394.8M) | (188.7M) | 77.1M | 21.6M | 2.2M |
| Non-Operating Income (excl Interest) | 383.7M | 177.4M | (91.9M) | (36.8M) | (13.4M) |
| EBT (Pre-Tax Income) | (238.1M) | (209.3M) | (633.7M) | (308.2M) | (41.9M) |
| Income Tax Expense | (3.3M) | (10.0M) | (42.3M) | (18.6M) | (17.7M) |
| Bottom Line | |||||
| Net Income | (168.2M) | (138.9M) | (413.1M) | (202.4M) | (7.2M) |
| Earnings from Cont. Ops | (234.7M) | (199.3M) | (591.4M) | (289.6M) | (24.2M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (168.2M) | (138.9M) | (413.1M) | (202.4M) | (7.2M) |
| Per Share | |||||
| Basic EPS | ($1.60) | ($1.30) | ($3.54) | ($1.79) | ($0.07) |
| Diluted EPS | ($1.60) | ($1.30) | ($3.54) | ($1.79) | ($0.07) |
| Revenue Per Share | $2.20 | $2.26 | $2.16 | $2.23 | $2.20 |
| Shares | |||||
| Basic Shares Outstanding | 105.8M | 106.7M | 116.6M | 112.8M | 101.1M |
| Diluted Shares Outstanding | 105.8M | 106.7M | 116.6M | 112.8M | 101.1M |
| Profitability Metrics | |||||
| EBITDA | (190.4M) | (162.2M) | (567.2M) | (241.2M) | 26.2M |
| D&A | 36.5M | 35.8M | 51.7M | 51.8M | 56.9M |
| EBIT | (226.9M) | (198.0M) | (618.9M) | (293.0M) | (30.7M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026